Medical Care

Global Uterine Cancer Therapies and Diagnostic Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Uterine Cancer Therapies and Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Uterine Cancer Therapies and Diagnostic.
The Uterine Cancer Therapies and Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Uterine Cancer Therapies and Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Uterine Cancer Therapies and Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ariad Pharmaceuticals
Merck
AbbVie
BD
Segment by Type
Uterine Sarcomas
Endometrial Carcinomas
Segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Uterine Cancer Therapies and Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Uterine Cancer Therapies and Diagnostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Uterine Sarcomas
1.2.3 Endometrial Carcinomas
1.3 Market by Application
1.3.1 Global Uterine Cancer Therapies and Diagnostic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Uterine Cancer Therapies and Diagnostic Market Perspective (2020-2031)
2.2 Global Uterine Cancer Therapies and Diagnostic Growth Trends by Region
2.2.1 Global Uterine Cancer Therapies and Diagnostic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Uterine Cancer Therapies and Diagnostic Historic Market Size by Region (2020-2025)
2.2.3 Uterine Cancer Therapies and Diagnostic Forecasted Market Size by Region (2026-2031)
2.3 Uterine Cancer Therapies and Diagnostic Market Dynamics
2.3.1 Uterine Cancer Therapies and Diagnostic Industry Trends
2.3.2 Uterine Cancer Therapies and Diagnostic Market Drivers
2.3.3 Uterine Cancer Therapies and Diagnostic Market Challenges
2.3.4 Uterine Cancer Therapies and Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Uterine Cancer Therapies and Diagnostic Players by Revenue
3.1.1 Global Top Uterine Cancer Therapies and Diagnostic Players by Revenue (2020-2025)
3.1.2 Global Uterine Cancer Therapies and Diagnostic Revenue Market Share by Players (2020-2025)
3.2 Global Uterine Cancer Therapies and Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Uterine Cancer Therapies and Diagnostic Revenue
3.4 Global Uterine Cancer Therapies and Diagnostic Market Concentration Ratio
3.4.1 Global Uterine Cancer Therapies and Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Uterine Cancer Therapies and Diagnostic Revenue in 2024
3.5 Global Key Players of Uterine Cancer Therapies and Diagnostic Head office and Area Served
3.6 Global Key Players of Uterine Cancer Therapies and Diagnostic, Product and Application
3.7 Global Key Players of Uterine Cancer Therapies and Diagnostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Uterine Cancer Therapies and Diagnostic Breakdown Data by Type
4.1 Global Uterine Cancer Therapies and Diagnostic Historic Market Size by Type (2020-2025)
4.2 Global Uterine Cancer Therapies and Diagnostic Forecasted Market Size by Type (2026-2031)
5 Uterine Cancer Therapies and Diagnostic Breakdown Data by Application
5.1 Global Uterine Cancer Therapies and Diagnostic Historic Market Size by Application (2020-2025)
5.2 Global Uterine Cancer Therapies and Diagnostic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Uterine Cancer Therapies and Diagnostic Market Size (2020-2031)
6.2 North America Uterine Cancer Therapies and Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Uterine Cancer Therapies and Diagnostic Market Size by Country (2020-2025)
6.4 North America Uterine Cancer Therapies and Diagnostic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Uterine Cancer Therapies and Diagnostic Market Size (2020-2031)
7.2 Europe Uterine Cancer Therapies and Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Uterine Cancer Therapies and Diagnostic Market Size by Country (2020-2025)
7.4 Europe Uterine Cancer Therapies and Diagnostic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Uterine Cancer Therapies and Diagnostic Market Size (2020-2031)
8.2 Asia-Pacific Uterine Cancer Therapies and Diagnostic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Uterine Cancer Therapies and Diagnostic Market Size by Region (2020-2025)
8.4 Asia-Pacific Uterine Cancer Therapies and Diagnostic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Uterine Cancer Therapies and Diagnostic Market Size (2020-2031)
9.2 Latin America Uterine Cancer Therapies and Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Uterine Cancer Therapies and Diagnostic Market Size by Country (2020-2025)
9.4 Latin America Uterine Cancer Therapies and Diagnostic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Uterine Cancer Therapies and Diagnostic Market Size (2020-2031)
10.2 Middle East & Africa Uterine Cancer Therapies and Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Uterine Cancer Therapies and Diagnostic Market Size by Country (2020-2025)
10.4 Middle East & Africa Uterine Cancer Therapies and Diagnostic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ariad Pharmaceuticals
11.1.1 Ariad Pharmaceuticals Company Details
11.1.2 Ariad Pharmaceuticals Business Overview
11.1.3 Ariad Pharmaceuticals Uterine Cancer Therapies and Diagnostic Introduction
11.1.4 Ariad Pharmaceuticals Revenue in Uterine Cancer Therapies and Diagnostic Business (2020-2025)
11.1.5 Ariad Pharmaceuticals Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Uterine Cancer Therapies and Diagnostic Introduction
11.2.4 Merck Revenue in Uterine Cancer Therapies and Diagnostic Business (2020-2025)
11.2.5 Merck Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Uterine Cancer Therapies and Diagnostic Introduction
11.3.4 AbbVie Revenue in Uterine Cancer Therapies and Diagnostic Business (2020-2025)
11.3.5 AbbVie Recent Development
11.4 BD
11.4.1 BD Company Details
11.4.2 BD Business Overview
11.4.3 BD Uterine Cancer Therapies and Diagnostic Introduction
11.4.4 BD Revenue in Uterine Cancer Therapies and Diagnostic Business (2020-2025)
11.4.5 BD Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Uterine Cancer Therapies and Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Uterine Sarcomas
Table 3. Key Players of Endometrial Carcinomas
Table 4. Global Uterine Cancer Therapies and Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Uterine Cancer Therapies and Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Uterine Cancer Therapies and Diagnostic Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Uterine Cancer Therapies and Diagnostic Market Share by Region (2020-2025)
Table 8. Global Uterine Cancer Therapies and Diagnostic Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Uterine Cancer Therapies and Diagnostic Market Share by Region (2026-2031)
Table 10. Uterine Cancer Therapies and Diagnostic Market Trends
Table 11. Uterine Cancer Therapies and Diagnostic Market Drivers
Table 12. Uterine Cancer Therapies and Diagnostic Market Challenges
Table 13. Uterine Cancer Therapies and Diagnostic Market Restraints
Table 14. Global Uterine Cancer Therapies and Diagnostic Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Uterine Cancer Therapies and Diagnostic Market Share by Players (2020-2025)
Table 16. Global Top Uterine Cancer Therapies and Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Uterine Cancer Therapies and Diagnostic as of 2024)
Table 17. Ranking of Global Top Uterine Cancer Therapies and Diagnostic Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Uterine Cancer Therapies and Diagnostic Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Uterine Cancer Therapies and Diagnostic, Headquarters and Area Served
Table 20. Global Key Players of Uterine Cancer Therapies and Diagnostic, Product and Application
Table 21. Global Key Players of Uterine Cancer Therapies and Diagnostic, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Uterine Cancer Therapies and Diagnostic Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Uterine Cancer Therapies and Diagnostic Revenue Market Share by Type (2020-2025)
Table 25. Global Uterine Cancer Therapies and Diagnostic Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Uterine Cancer Therapies and Diagnostic Revenue Market Share by Type (2026-2031)
Table 27. Global Uterine Cancer Therapies and Diagnostic Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Uterine Cancer Therapies and Diagnostic Revenue Market Share by Application (2020-2025)
Table 29. Global Uterine Cancer Therapies and Diagnostic Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Uterine Cancer Therapies and Diagnostic Revenue Market Share by Application (2026-2031)
Table 31. North America Uterine Cancer Therapies and Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Uterine Cancer Therapies and Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Uterine Cancer Therapies and Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Uterine Cancer Therapies and Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Uterine Cancer Therapies and Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Uterine Cancer Therapies and Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Uterine Cancer Therapies and Diagnostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Uterine Cancer Therapies and Diagnostic Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Uterine Cancer Therapies and Diagnostic Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Uterine Cancer Therapies and Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Uterine Cancer Therapies and Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Uterine Cancer Therapies and Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Uterine Cancer Therapies and Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Uterine Cancer Therapies and Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Uterine Cancer Therapies and Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 46. Ariad Pharmaceuticals Company Details
Table 47. Ariad Pharmaceuticals Business Overview
Table 48. Ariad Pharmaceuticals Uterine Cancer Therapies and Diagnostic Product
Table 49. Ariad Pharmaceuticals Revenue in Uterine Cancer Therapies and Diagnostic Business (2020-2025) & (US$ Million)
Table 50. Ariad Pharmaceuticals Recent Development
Table 51. Merck Company Details
Table 52. Merck Business Overview
Table 53. Merck Uterine Cancer Therapies and Diagnostic Product
Table 54. Merck Revenue in Uterine Cancer Therapies and Diagnostic Business (2020-2025) & (US$ Million)
Table 55. Merck Recent Development
Table 56. AbbVie Company Details
Table 57. AbbVie Business Overview
Table 58. AbbVie Uterine Cancer Therapies and Diagnostic Product
Table 59. AbbVie Revenue in Uterine Cancer Therapies and Diagnostic Business (2020-2025) & (US$ Million)
Table 60. AbbVie Recent Development
Table 61. BD Company Details
Table 62. BD Business Overview
Table 63. BD Uterine Cancer Therapies and Diagnostic Product
Table 64. BD Revenue in Uterine Cancer Therapies and Diagnostic Business (2020-2025) & (US$ Million)
Table 65. BD Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
Table 69. Authors List of This Report


List of Figures
Figure 1. Uterine Cancer Therapies and Diagnostic Picture
Figure 2. Global Uterine Cancer Therapies and Diagnostic Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Uterine Cancer Therapies and Diagnostic Market Share by Type: 2024 VS 2031
Figure 4. Uterine Sarcomas Features
Figure 5. Endometrial Carcinomas Features
Figure 6. Global Uterine Cancer Therapies and Diagnostic Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Uterine Cancer Therapies and Diagnostic Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Specialty Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Uterine Cancer Therapies and Diagnostic Report Years Considered
Figure 13. Global Uterine Cancer Therapies and Diagnostic Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Uterine Cancer Therapies and Diagnostic Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Uterine Cancer Therapies and Diagnostic Market Share by Region: 2024 VS 2031
Figure 16. Global Uterine Cancer Therapies and Diagnostic Market Share by Players in 2024
Figure 17. Global Top Uterine Cancer Therapies and Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Uterine Cancer Therapies and Diagnostic as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Uterine Cancer Therapies and Diagnostic Revenue in 2024
Figure 19. North America Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Uterine Cancer Therapies and Diagnostic Market Share by Country (2020-2031)
Figure 21. United States Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Uterine Cancer Therapies and Diagnostic Market Share by Country (2020-2031)
Figure 25. Germany Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Uterine Cancer Therapies and Diagnostic Market Share by Region (2020-2031)
Figure 33. China Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Uterine Cancer Therapies and Diagnostic Market Share by Country (2020-2031)
Figure 41. Mexico Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Uterine Cancer Therapies and Diagnostic Market Share by Country (2020-2031)
Figure 45. Turkey Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Ariad Pharmaceuticals Revenue Growth Rate in Uterine Cancer Therapies and Diagnostic Business (2020-2025)
Figure 49. Merck Revenue Growth Rate in Uterine Cancer Therapies and Diagnostic Business (2020-2025)
Figure 50. AbbVie Revenue Growth Rate in Uterine Cancer Therapies and Diagnostic Business (2020-2025)
Figure 51. BD Revenue Growth Rate in Uterine Cancer Therapies and Diagnostic Business (2020-2025)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies